ANPI Angiotech Pharmaceuticals - Common Shares (MM)

Angiotech to host year-in-review presentation from 2004 Annual General Meeting of Shareholders VANCOUVER, June 3 /PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI; TSX: ANP), a specialty pharmaceutical company focusing on drug-coated medical devices and biomaterials, will host a live webcast of a year-in-review presentation to shareholders at its annual general meeting on Thursday, June 10, 2004 beginning at 9:45 am PST (12:45 pm EST). The annual general meeting will be held at Simon Fraser University's Center for Dialogue, in Vancouver, BC, Canada. The presentation will be hosted by Dr. William Hunter, President and Chief Executive Officer of Angiotech. The webcast will be available to all interested parties through Angiotech's website at http://www.angiotech.com/ under the Investor Relations section and on a listen-only basis by dialing toll-free at 1-800-299-9630 and entering Access Code 88244642. To ensure a timely connection to the webcast it is recommended that users register approximately 15 minutes before the presentation. An audio recording of the presentation will be available until June 17, 2004 by calling 1-888-286-8010 and entering Access Code 60646225. Vancouver-based Angiotech Pharmaceuticals, Inc., a specialty pharmaceutical company focusing on drug-coated medical devices and biomaterials, is dedicated to enhancing the performance of medical devices and biomaterials through the innovative uses of pharmacotherapeutics. To find out more about Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPI)(TSE:ANP), please visit our website at http://www.angiotech.com/. For more information contact: Media: Eric Starkman Starkman & Associates (212) 252-8545 Analysts: Rui Avelar Angiotech Pharmaceuticals, Inc. (604) 221-7676 ext 6996 Investors: Ian Harper Angiotech Pharmaceuticals, Inc. (604) 221-7676 ext 6933 DATASOURCE: Angiotech Pharmaceuticals, Inc. CONTACT: Media: Eric Starkman, Starkman & Associates, (212) 252-8545; Analysts: Rui Avelar, Angiotech Pharmaceuticals, Inc., (604) 221-7676 ext 6996; Investors: Ian Harper, Angiotech Pharmaceuticals, Inc., (604) 221-7676 ext 6933

Copyright